ARTICLE | Clinical News
Ciba Corning Diagnostics Corp. regulatory update
September 26, 1994 7:00 AM UTC
Ciba Corning received FDA approval to market the ACS PSA immunoassay, a direct chemiluminescent blood test that determines the level of prostate specific antigen (PSA). The Norwood, Mass., company sai...